The virtual cone: A novel technique to generate spherical dose distributions using a multileaf collimator and standardized control-point sequence for small target radiation surgery

Viability of the virtual cone technique using a fixed small multi-leaf collimator field for stereotactic radiosurgery of trigeminal neuralgia

Dosimetric uncertainties in very small (≤1.5 × 1.5 cm2 ) photon fields are remarkably higher, which undermines the validity of the virtual cone (VC) technique with a diminutive and variable MLC fields. We evaluate the accuracy and reproducibility of the VC method with a very small, fixed MLC field setting, called a fixed virtual cone (fVC), for small target radiosurgery such as trigeminal neuralgia (TGN). The fVC is characterized by 0.5 cm x 0.5 cm high-definition (HD) MLC field of 10MV FFF beam defined at 100 cm SAD, while backup jaws are positioned at 1.5 cm x 1.5 cm. A spherical dose distribution equivalent to 5 mm (diameter) physical cone was generated using 10-14 non-coplanar, partial arcs. Dosimetric accuracy was validated using SRS diode (PTW 60018), SRS MapCHECK (SNC) measurements. As a quality assurance measure, 10 treatment plans (SRS) for TGN, consisting of various arc ranges at different collimator angles were analyzed using 6 MV FFF and 10 MV FFF beams, including a field-by-field study (n = 130 fields). Dose outputs were compared between the Eclipse TPS and measurements (SRS MapCHECK). Moreover, dosimetric changes in the field defining fVC, prompted by a minute (± 0.5-1.0 mm) leaf shift, was examined among TPS, diode measurements, and Monte Carlo (MC) simulations. The beam model for fVC was validated (≤3% difference) using SRS MapCHECK based absolute dose measurements. The equivalent diameters of the 50% isodose distribution were found comparable to that of a 5 mm cone. Additionally, the comparison of field output factors, dose per MU between the TPS and SRS diode measurements using the fVC field, including ± 1 mm leaf shift, yielded average discrepancies within 5.5% and 3.5% for 6 MV FFF and 10 MV FFF beams, respectively. Overall, the fVC method is a credible alternative to the physical cone (5 mm) that can be applied in routine radiosurgical treatment of TGN.

Connectomic Basis for Tremor Control in Stereotactic Radiosurgical Thalamotomy

BACKGROUND AND PURPOSE

Given the increased use of stereotactic radiosurgical thalamotomy and other ablative therapies for tremor, new biomarkers are needed to improve outcomes. Using resting-state fMRI and MR tractography, we hypothesized that a "connectome fingerprint" can predict tremor outcomes and potentially serve as a targeting biomarker for stereotactic radiosurgical thalamotomy.

MATERIALS AND METHODS

We evaluated 27 patients who underwent unilateral stereotactic radiosurgical thalamotomy for essential tremor or tremor-predominant Parkinson disease. Percentage postoperative improvement in the contralateral limb Fahn-Tolosa-Marin Clinical Tremor Rating Scale (TRS) was the primary end point. Connectome-style resting-state fMRI and MR tractography were performed before stereotactic radiosurgery. Using the final lesion volume as a seed, "connectivity fingerprints" representing ideal connectivity maps were generated as whole-brain R-maps using a voxelwise nonparametric Spearman correlation. A leave-one-out cross-validation was performed using the generated R-maps.

RESULTS

The mean improvement in the contralateral tremor score was 55.1% (SD, 38.9%) at a mean follow-up of 10.0 (SD, 5.0) months. Structural connectivity correlated with contralateral TRS improvement (r = 0.52; P  = .006) and explained 27.0% of the variance in outcome. Functional connectivity correlated with contralateral TRS improvement (r = 0.50; P  = .008) and explained 25.0% of the variance in outcome. Nodes most correlated with tremor improvement corresponded to areas of known network dysfunction in tremor, including the cerebello-thalamo-cortical pathway and the primary and extrastriate visual cortices.

CONCLUSIONS

Stereotactic radiosurgical targets with a distinct connectivity profile predict improvement in tremor after treatment. Such connectomic fingerprints show promise for developing patient-specific biomarkers to guide therapy with stereotactic radiosurgical thalamotomy.

Radiosurgical treatment of solitary brain metastases using virtual cones with a standard multileaf collimator

PURPOSE

The virtual cone has been previously introduced as a novel technique for generating small, spherical dose distributions using a high-definition multileaf collimator (MLC) for functional radiosurgery applications. There has been no reported investigation into adapting this technique to a standard MLC for the treatment of solitary intracranial metastases as an alternative to physical stereotactic cones. This study characterizes the virtual cone technique adapted to a standard 5 mm leaf-width MLC (VC_SD ).

METHODS

VC_SD dose distributions using MLC leaf gaps of 2-5 mm were generated and isodose sphericity metrics, peak dose gradients, optimal normalization ranges, and achievable field widths were compared to those of 5.0-12.5 mm diameter physical cones. Target sizes feasible to treat were identified and planned for comparison against established techniques using Paddick conformity index (PCI) and dose volume metrics. End-to-end validation of the VC_SD technique was performed.

RESULTS

VC_SD and physical cones sphericity metrics agree within 3.5% and VC_SD plans achieved a dose gradient of 21.3% mm^-1 , comparable to 10.0-12.5 mm diameter physical cones. Normalization within the 50%-77% range preserves the optimal dose gradient within 2%⋅mm^-1 and enables the treatment of 5-11 mm diameter planning target volumes (PTVs). Mean PCI for virtual and physical cones was 0.957 and 0.949, which compared favorably against conformal arc and VMAT (0.899 and 0.926). VC_SD outperformed conformal arc and VMAT for all dose volume metrics, and the mean 50% dose volume differed from physical cones by < 0.5cc for PTVs as small as 5 mm. Validation measurements showed 100% of points passing a 2% / 0.5 mm gamma test for all plans.

CONCLUSIONS

The VC_SD technique efficiently generates spherical dose distributions for the treatment of small brain metastases. Characteristics of the VC_SD dose distributions are sufficiently comparable to those of physical cones to support VC_SD as an alternative for the treatment of spherical PTVs as small as 5 mm in diameter.

Determination of commissioning criteria for multileaf-collimator, stereotactic radiosurgery treatments on Varian TrueBeam and Edge machines using a novel anthropomorphic phantom

An anthropomorphic phantom has been developed by Varian Medical Systems for commissioning multileaf‐collimator (MLC), stereotactic radiosurgery (SRS) treatments on Varian TrueBeam and Edge linear accelerators. Northwest Medical Physics Center (NMPC) has collected end‐to‐end data on these machines, at six independent clinical sites, to establish baseline dosimetric and geometric commissioning criteria for SRS measurements with this phantom. The Varian phantom is designed to accommodate four interchangeable target cassettes, each designed for a specific quality assurance function. End‐to‐end measurements utilized the phantom to verify the coincidence of treatment isocenter with a hidden target in a Winston‐Lutz cassette after localization using cone‐beam computed tomography (CBCT). Dose delivery to single target (2 cm) and single‐isocenter, multitarget (2 and 1 cm) geometries was verified using ionization chamber and EBT3 film cassettes. A nominal dose of 16 Gy was prescribed for each plan using a site's standard beam geometry for SRS cases. Measurements were performed with three Millennium and three high‐definition MLC machines at beam energies of 6‐MV and 10‐MV flattening‐filter‐free energies. Each clinical site followed a standardized procedure for phantom simulation, treatment planning, quality assurance, and treatment delivery. All treatment planning and delivery was performed using ARIA oncology information system and Eclipse treatment planning software. The isocenter measurements and irradiated film were analyzed using DoseLab quality assurance software; gamma criteria of 3%/1 mm, 3%/0.5 mm, and 2%/1 mm were applied for film analysis. Based on the data acquired in this work, the recommended commissioning criteria for end‐to‐end SRS measurements with the Varian phantom are as follows: coincidence of treatment isocenter and CBCT‐aligned hidden target < 1 mm, agreement of measured chamber dose with calculated dose ≤ 5%, and film gamma passing > 90% for gamma criteria of 3%/1 mm after DoseLab auto‐registration shifts ≤ 1 mm in any direction.

Commissioning a multileaf collimator virtual cone for the stereotactic radiosurgery of trigeminal neuralgia

A multileaf collimator (MLC), virtual‐cone treatment technique has been commissioned for trigeminal neuralgia (TGN) at Tri‐Cities Cancer Center (TCCC). This novel technique was initially developed at the University of Alabama in Birmingham (UAB); it is designed to produce a spherical dose profile similar to a fixed, 5‐mm conical collimator distribution. Treatment is delivered with a 10‐MV flattening‐filter‐free (FFF) beam using a high‐definition MLC on a Varian Edge linear accelerator. Absolute dose output and profile measurements were performed in a 20 × 20 × 14 cm³ solid‐water phantom using an Exradin W2 scintillation detector and Gafchromic EBT3 film. Dose output constancy for the virtual cone was evaluated over 6 months using an Exradin A11 parallel plate chamber. The photo‐neutron dose generated by these treatments was assessed at distances of 50 and 100 cm from isocenter using a Ludlum Model 30–7 Series Neutron Meter. TGN treatments at TCCC have been previously delivered at 6‐MV FFF using a 5‐mm stereotactic cone. To assess the dosimetric impact of using a virtual cone, eight patients previously treated for TGN with a 5‐mm cone were re‐planned using a virtual cone. Seven patients have now been treated for TGN using a virtual cone at TCCC. Patient‐specific quality assurance was performed for each patient using Gafchromic EBT‐XD film inside a Standard Imaging Stereotactic Dose Verification Phantom. The commissioning results demonstrate that the virtual‐cone dosimetry, first described at UAB, is reproducible on a second Edge linear accelerator at an independent clinical site. The virtual cone is a credible alternative to a physical, stereotactic cone for the treatment of TGN at TCCC.

Essential tremor

Essential tremor (ET) is one of the most common movement disorders, with a reported >60 million affected individuals worldwide. The definition and underlying pathophysiology of ET are contentious. Patients present primarily with motor features such as postural and action tremors, but may also have other non-motor features, including cognitive impairment and neuropsychiatric symptoms. Genetics account for most of the ET risk but environmental factors may also be involved. However, the variable penetrance and challenges in validating data make gene-environment analysis difficult. Structural changes in cerebellar Purkinje cells and neighbouring neuronal populations have been observed in post-mortem studies, and other studies have found GABAergic dysfunction and dysregulation of the cerebellar-thalamic-cortical circuitry. Commonly prescribed medications include propranolol and primidone. Deep brain stimulation and ultrasound thalamotomy are surgical options in patients with medically intractable ET. Further research in post-mortem studies, and animal and cell-based models may help identify new pathophysiological clues and therapeutic targets and, together with advances in omics and machine learning, may facilitate the development of precision medicine for patients with ET.

Investigating the impacts of intrafraction motion on dosimetric outcomes when treating small targets with virtual cones

Purpose

Intrafraction patient motion is a well‐documented phenomenon in radiation therapy. In stereotactic radiosurgery applications in which target sizes can be very small and dose gradients very steep, patient motion can significantly impact the magnitude and positional accuracy of the delivered dose. This work investigates the impact of intrafraction motion on dose metrics for small targets when treated with a virtual cone.

Materials and Methods

Monte Carlo simulations were performed to calculate dose kernels for treatment apertures ranging from 1 × 2.5 mm² to 10 × 10 mm². The phantom was an 8.2‐cm diameter sphere and isotropic voxels had lengths of 0.25 mm. Simulated treatments consisted of 3 arcs: 1 axial arc (360° gantry rotation, couch angle 0°) and 2 oblique arcs (180° gantry rotation, couch angle ±45°). Dose distributions were calculated via superposition of the rotated kernels. Two different collimator orientations were considered to create a virtual cone: (a) each treatment arc was delivered twice, once each with a static collimator angle of ±45°, and (b) each treatment arc was delivered once, with dynamic collimator rotation throughout the arc. Two different intrafraction motion patterns were considered: (a) constant linear motion and (b) sudden, persistent motion. The impact of motion on dose distributions for target sizes ranging from 1 to 10 mm diameter spheres was quantified as a function of the aperture size used to treat the lesions.

Results

The impact of motion on both the target and the surrounding tissue was a function of both aperture shape and target size. When a 0.5‐mm linear drift along each dimension occurred during treatment, targets ≥5 mm saw less than a 10% decrease in coverage by the prescription dose. Smaller apertures accrued larger penalties with respect to dosimetric hotspots seen in the tissues surrounding the target volume during intrafraction motion. For example, treating a 4‐mm‐sized target that undergoes 2.60 mm (3D vector) of continuous linear motion, the D₅ in the concentric shells that extend 1, 2, and 3 mm from the surface of the target was 39%, 24%, and 14% smaller, respectively when comparing the delivery of a larger aperture (6 × 10 mm²) to a smaller aperture (2 × 5 mm²). Using a static collimator for shaping a virtual cone during treatment minimized the dosimetric impact of motion in the majority of cases. For example, the volume that is covered by 70% or more of the prescription dose is smaller in 60.4% of cases when using the static collimator. The volume covered by 50, and 30% or more of the prescription dose is also smaller when treating with a static collimator, but the clinical significance of this finding is unknown.

Conclusions

In this work, the dosimetric trade‐offs between aperture size and target size when irradiating with virtual cones has been demonstrated. These findings provide information about the tradeoffs between target coverage and normal tissue sparing that may help inform clinical decision making when treating smaller targets with virtual cones.

Surface guided imaging during stereotactic radiosurgery with automated delivery

PURPOSE

To report on the use of surface guided imaging during frameless intracranial stereotactic radiotherapy with automated delivery via HyperArc^TM (Varian Medical Systems, Palo Alto, CA).

METHODS

All patients received intracranial radiotherapy with HyperArc^TM and were monitored for intrafraction motion by the AlignRT® (VisionRT, London, UK) surface imaging (SI) system. Immobilization was with the Encompass^TM (Qfix, Avondale, PA) aquaplast mask device. AlignRT® log files were correlated with trajectory log files to correlate treatment parameters with SI reported offsets. SI reported offsets were correlated with gantry angle and analyzed for performance issues at non-zero couch angles and during camera-pod blockage during gantry motion. Demographics in the treatment management system were used to identify race and determine if differences in SI reported offsets are due to skin tone settings.

RESULTS

A total of 981 fractions were monitored over 14 months and 819 were analyzed. The median AlignRT® reported motion from beginning to the end of treatment was 0.24 mm. The median offset before beam on at non-zero couch angles was 0.55 mm. During gantry motion when camera pods are blocked, the median magnitude was below 1 mm. Median magnitude of offsets at non-zero couch angles was not found to be significantly different for patients stratified by race.

CONCLUSIONS

Surface image guidance is a viable alternative to scheduled mid-treatment imaging for monitoring intrafraction motion during stereotactic radiosurgery with automated delivery.

Current and Emerging Treatments of Essential Tremor

Established medications that improve tremor include beta-adrenergic antagonists, primidone, topiramate, and ethanol. Less consistent efficacy is reported with many other medications, usually antiepileptic drugs. A number of investigational medications, including T-type calcium channel blockers and allosteric gamma-aminobutyric acid-A modulators, are being developed for tremor. Deep brain stimulation techniques continues to be refined and focused ultrasound thalamotomy now offers an incisionless surgical option. Finally a number of peripheral electrical and mechanical devices are under development for tremor.

Stereotactic radiosurgery with MLC-defined arcs: Verification of dosimetry, spatial accuracy, and end-to-end tests

Purpose

To measure dosimetric and spatial accuracy of stereotactic radiosurgery (SRS) delivered to targets as small as the trigeminal nerve (TN) using a standard external beam treatment planning system (TPS) and multileaf collimator‐(MLC) equipped linear accelerator without cones or other special attachments or modifications.

Methods

Dosimetric performance was assessed by comparing computed dose distributions to film measurements. Comparisons included the γ‐index, beam profiles, isodose lines, maximum dose, and spatial accuracy. Initially, single static 360° arcs of MLC‐shaped fields ranging from 1.6 × 5 to 30 × 30 mm² were planned and delivered to an in‐house built block phantom having approximate dimensions of a human head. The phantom was equipped with markings that allowed accurate setup using planar kV images. Couch walkout during multiple‐arc treatments was investigated by tracking a ball pointer, initially positioned at cone beam computed tomography (CBCT) isocenter, as the couch was rotated. Tracks were mapped with no load and a 90 kg stack of plastic plates simulating patient treatment. The dosimetric effect of walkout was assessed computationally by comparing test plans that corrected for walkout to plans that neglected walkout. The plans involved nine 160° arcs of 2.4 × 5 mm² fields applied at six different couch angles. For end‐to‐end tests that included CT simulation, target contouring, planning, and delivery, a cylindrical phantom mimicking a 3 mm lesion was constructed and irradiated with the nine‐arc regimen. The phantom, lacking markings as setup aids was positioned under CBCT guidance by registering its surface and internal structures with CTs from simulation. Radiochromic film passing through the target center was inserted parallel to the coronal and the sagittal plane for assessment of spatial and dosimetric accuracy.

Results

In the single‐arc block phantom tests computed maximum doses of all field sizes agreed with measurements within 2.4 ± 2.0%. Profile widths at 50% maximum agreed within 0.2 mm. The largest targeting error was 0.33 mm. The γ‐index (3%, 1 mm) averaged over 10 experiments was >1 in only 1% of pixels for field sizes up to 10 × 10 mm² and rose to 4.4% as field size increased to 20 × 20 mm². Table walkout was not affected by load. Walkout shifted the target up to 0.6 mm from CBCT isocenter but, according to computations shifted the dose cloud of the nine‐arc plan by only 0.16 mm. Film measurements verified the small dosimetric effect of walkout, allowing walkout to be neglected during planning and treatment. In the end‐to‐end tests average and maximum targeting errors were 0.30 ± 0.10 and 0.43 mm, respectively. Gamma analysis of coronal and sagittal dose distributions based on a 3%/0.3 mm agreement remained <1 at all pixels. To date, more than 50 functional SRS treatments using MLC‐shaped static field arcs have been delivered.

Conclusion

Stereotactic radiosurgery (SRS) can be planned and delivered on a standard linac without cones or other modifications with better than 0.5 mm spatial and 5% dosimetric accuracy.